1. Home
  2. COSM vs NCEL Comparison

COSM vs NCEL Comparison

Compare COSM & NCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cosmos Health Inc.

COSM

Cosmos Health Inc.

HOLD

Current Price

$0.51

Market Cap

18.8M

Sector

Health Care

ML Signal

HOLD

NCEL

NewcelX Ltd. Ordinary Shares

N/A

Current Price

$2.42

Market Cap

20.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
COSM
NCEL
Founded
2009
2008
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Other Pharmaceuticals
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.8M
20.7M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
COSM
NCEL
Price
$0.51
$2.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
456.0K
126.6K
Earning Date
11-17-2025
12-01-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$59,792,819.00
N/A
Revenue This Year
$28.14
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.69
N/A
52 Week Low
$0.28
$1.89
52 Week High
$1.32
$7.64

Technical Indicators

Market Signals
Indicator
COSM
NCEL
Relative Strength Index (RSI) 46.17 N/A
Support Level $0.48 N/A
Resistance Level $0.56 N/A
Average True Range (ATR) 0.04 0.00
MACD 0.01 0.00
Stochastic Oscillator 40.83 0.00

Price Performance

Historical Comparison
COSM
NCEL

About COSM Cosmos Health Inc.

Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.

About NCEL NewcelX Ltd. Ordinary Shares

NewcelX Ltd is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company's integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. It has research and development operations in Ness Ziona, Israel.

Share on Social Networks: